Artrya Limited ( (AU:AYA) ) just unveiled an update.
Artrya Limited announced the issuance of 110,000 ordinary shares following the conversion of vested employee incentive performance rights. This move reflects the company’s ongoing commitment to incentivizing its workforce and may enhance its operational capabilities in the medical technology sector, particularly in the development of AI-driven healthcare solutions.
More about Artrya Limited
Artrya Limited is an applied artificial intelligence healthcare company based in Perth, Australia. Founded in 2018 and listed on the Australian Securities Exchange in 2021, Artrya focuses on improving the diagnosis of coronary heart disease through its AI platform. The company collaborates with clinicians to develop deep-learning algorithms aimed at predicting and preventing acute coronary events, with regulatory submissions pending in the US.
YTD Price Performance: 52.83%
Average Trading Volume: 164,896
Technical Sentiment Consensus Rating: Sell
See more data about AYA stock on TipRanks’ Stock Analysis page.